Metabocentric Biotechnologies Inc. is an early stage biopharmaceutical company focused on the development of new therapies for the treatment of diseases, including cancer and diabetes, through the strategic modulation of cellular metabolism. The company was founded by three scientists at the University of Houston. UH has awarded the company two exclusive, world-wide licenses for technologies of cancer treatment. The mission of the company is to advance these cancer therapeutical technologies to the clinic to save lives of cancer patients.
Inventing Metabolism-Based Therapies for Disease